Insider Trading activities at Pacific Biosciences Of California, Inc. (PACB)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pacific Biosciences Of California, Inc. (PACB) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pacific Biosciences Of California, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1299130.

Total stock buying since 2015: $35,353.
Total stock sales since 2015: $180,262,421.
Total stock option exercises since 2015: $22,532,247.


19 insiders reported insider trading activities at Pacific Biosciences Of California, Inc. (PACB):
Insider trading activities of Barnes Susan K
Insider trading activities of Shapiro Lucy
Insider trading activities of Van Oene Mark
Insider trading activities of Schaefer Eric
Insider trading activities of Ordonez Kathy
Insider trading activities of Farmer Michele
Insider trading activities of Ericson William W.
Insider trading activities of Eidel Jeff
Insider trading activities of Corcoran Kevin P
Insider trading activities of Hunkapiller Michael
Insider trading activities of Fromen Peter
Insider trading activities of Livingston Randall S
Insider trading activities of Botstein David
Insider trading activities of Henry Christian O
Insider trading activities of Dow Brian B
Insider trading activities of Kim Susan G.
Insider trading activities of Milligan John F
Insider trading activities of Phillips James Michael
Insider trading activities of Mohr Marshall

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Pacific Biosciences Of California, Inc. (PACB).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 451,467 $833,447 0 $0
2024 0 $0 380,711 $1,521,356 386,621 $1,111,132
2023 0 $0 278,239 $2,794,181 50,000 $127,000
2022 0 $0 175,512 $1,565,354 60,000 $153,300
2021 0 $0 2,894,379 $109,786,449 2,593,377 $13,928,195
2020 0 $0 4,857,614 $62,669,584 810,000 $3,243,394
2019 0 $0 39,486 $283,187 0 $0
2018 0 $0 25,000 $188,500 341,990 $1,096,377
2017 0 $0 0 $0 888,738 $2,352,558
2016 0 $0 60,000 $543,360 161,666 $498,127
2015 7,196 $35,353 16,689 $77,003 31,663 $22,164

Table 2. Monthly summary of insider trading at Pacific Biosciences Of California, Inc. (PACB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 0 $0 26,836 $35,181 0 $0
2025-05 0 $0 5,195 $5,200 0 $0
2025-02 0 $0 385,031 $723,087 0 $0
2025-01 0 $0 34,405 $69,979 0 $0
2024-09 0 $0 118,689 $206,755 0 $0
2024-08 0 $0 64,771 $105,775 0 $0
2024-05 0 $0 5,275 $10,708 0 $0
2024-03 0 $0 0 $0 386,621 $1,111,132
2024-02 0 $0 160,964 $957,062 0 $0
2024-01 0 $0 31,012 $241,056 0 $0
2023-12 0 $0 20,000 $200,000 0 $0
2023-09 0 $0 126,101 $1,247,245 0 $0
2023-08 0 $0 62,038 $666,965 0 $0
2023-05 0 $0 5,165 $65,027 25,000 $63,500
2023-03 0 $0 35,776 $335,148 25,000 $63,500
2023-02 0 $0 2,437 $25,029 0 $0
2023-01 0 $0 26,722 $254,767 0 $0
2022-09 0 $0 104,275 $600,282 0 $0
2022-06 0 $0 0 $0 35,000 $64,050
2022-05 0 $0 3,573 $19,819 0 $0
2022-02 0 $0 6,464 $72,997 0 $0
2022-01 0 $0 61,200 $872,256 25,000 $89,250
2021-09 0 $0 110,792 $2,957,897 0 $0
2021-05 0 $0 37,500 $980,662 37,500 $232,687

Table 3. Detailed insider trading at Pacific Biosciences Of California, Inc. (PACB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-18 Van Oene Mark (See Remarks) Sale 26,836 1.31 35,181
2025-05-19 Farmer Michele (See Remarks) Sale 5,195 1.00 5,200
2025-02-18 Farmer Michele (See Remarks) Sale 24,349 1.88 45,727
2025-02-18 Van Oene Mark (See Remarks) Sale 100,773 1.88 189,251
2025-02-18 Henry Christian O (See Remarks) Sale 259,909 1.88 488,109
2025-01-10 Van Oene Mark (See Remarks) Sale 34,405 2.03 69,979
2024-09-30 Kim Susan G. (See Remarks) Sale 19,782 1.72 34,064
2024-09-16 Henry Christian O (See Remarks) Sale 98,907 1.75 172,691
2024-08-19 Eidel Jeff (See Remarks) Sale 26,760 1.59 42,601
2024-08-16 Van Oene Mark (See Remarks) Sale 38,011 1.66 63,174
2024-05-20 Farmer Michele (See Remarks) Sale 5,275 2.03 10,708
2024-03-15 Ordonez Kathy (Director) Option Ex 361,621 2.77 999,882
2024-03-01 Mohr Marshall (Director) Option Ex 25,000 4.45 111,250
2024-02-20 Kim Susan G. (See Remarks) Sale 831 5.26 4,371
2024-02-20 Henry Christian O (See Remarks) Sale 1,979 5.26 10,411
2024-02-16 Eidel Jeff (See Remarks) Sale 15,498 5.96 92,337
2024-02-16 Farmer Michele (See Remarks) Sale 7,562 5.96 45,054
2024-02-16 Kim Susan G. (See Remarks) Sale 22,496 5.96 134,031
2024-02-16 Van Oene Mark (See Remarks) Sale 33,560 5.96 199,950
2024-02-16 Henry Christian O (See Remarks) Sale 79,038 5.96 470,908
2024-01-09 Van Oene Mark (See Remarks) Sale 31,012 7.77 241,056
2023-12-14 Henry Christian O (See Remarks) Sale 20,000 10.00 200,000
2023-09-29 Kim Susan G. (See Remarks) Sale 19,257 8.44 162,471
2023-09-18 Henry Christian O (See Remarks) Sale 96,844 10.12 980,254
2023-09-11 Henry Christian O (See Remarks) Sale 10,000 10.45 104,520
2023-08-17 Eidel Jeff (See Remarks) Sale 25,936 10.60 274,843
2023-08-17 Henry Christian O (See Remarks) Sale 10,000 10.50 105,000
2023-08-16 Van Oene Mark (See Remarks) Sale 26,102 11.00 287,122
2023-05-18 Farmer Michele (See Remarks) Sale 5,165 12.59 65,027
2023-05-18 Mohr Marshall Option Ex 25,000 2.54 63,500
2023-03-15 Ericson William W. (Director) Sale 7,541 8.90 67,114
2023-03-15 Ericson William W. (Director) Option Ex 25,000 2.54 63,500
2023-03-03 Farmer Michele (See Remarks) Sale 3,153 9.49 29,931
2023-03-03 Kim Susan G. (See Remarks) Sale 5,045 9.49 47,892
2023-03-03 Van Oene Mark (See Remarks) Sale 6,268 9.49 59,502
2023-03-03 Henry Christian O (See Remarks) Sale 13,769 9.49 130,709
2023-02-17 Kim Susan G. (See Remarks) Sale 907 10.27 9,315
2023-02-17 Henry Christian O (See Remarks) Sale 1,530 10.27 15,714
2023-01-10 Van Oene Mark (See Remarks) Sale 26,722 9.53 254,767
2022-09-29 Kim Susan G. (See Remarks) Sale 12,968 5.61 72,802
2022-09-15 Henry Christian O (See Remarks) Sale 91,307 5.78 527,480
2022-06-10 Mohr Marshall (Director) Option Ex 35,000 1.83 64,050
2022-05-18 Farmer Michele (See Remarks) Sale 3,573 5.55 19,819
2022-02-17 Kim Susan G. (Chief Financial Officer) Sale 1,062 11.06 11,745
2022-02-17 Henry Christian O (President & CEO) Sale 2,122 11.09 23,532
2022-02-16 Ordonez Kathy (Director) Sale 3,280 11.50 37,720
2022-01-14 Mohr Marshall (Director) Option Ex 25,000 3.57 89,250
2022-01-11 Fromen Peter (Chief Commercial Officer) Sale 19,720 14.30 281,996
2022-01-11 Van Oene Mark (Chief Operating Officer) Sale 41,480 14.23 590,260
2021-09-29 Kim Susan G. (Chief Financial Officer) Sale 20,272 25.75 522,004
2021-09-16 Henry Christian O (President & CEO) Sale 90,520 26.91 2,435,893
2021-05-25 Ericson William W. (Director) Sale 37,500 26.15 980,662
2021-05-25 Ericson William W. (Director) Option Ex 37,500 6.21 232,687
2021-02-26 Hunkapiller Michael (Director) Sale 234,246 32.06 7,510,395
2021-02-26 Hunkapiller Michael (Director) Option Ex 234,246 6.29 1,472,704
2021-02-25 Hunkapiller Michael (Director) Sale 339,377 33.42 11,341,300
2021-02-25 Hunkapiller Michael (Director) Option Ex 339,377 6.29 2,133,663
2021-02-24 Hunkapiller Michael (Director) Sale 266,427 36.96 9,846,076
2021-02-24 Hunkapiller Michael (Director) Option Ex 266,427 6.25 1,665,168
2021-02-23 Hunkapiller Michael (Director) Sale 373,321 33.96 12,679,101
2021-02-23 Hunkapiller Michael (Director) Option Ex 373,321 5.53 2,062,971
2021-02-22 Schaefer Eric (Chief Accounting Officer) Sale 3,842 39.20 150,606
2021-02-22 Hunkapiller Michael (Director) Sale 229,127 39.15 8,970,322
2021-02-22 Hunkapiller Michael (Director) Option Ex 229,127 5.53 1,266,155
2021-02-16 Ordonez Kathy (Director) Sale 220,771 48.35 10,674,277
2021-02-16 Ordonez Kathy (Director) Option Ex 185,879 5.18 963,224
2021-02-12 Botstein David (Director) Sale 160,000 49.85 7,976,000
2021-02-12 Botstein David (Director) Option Ex 160,000 4.58 733,280
2021-02-12 Shapiro Lucy (Director) Sale 101,666 50.40 5,123,966
2021-02-12 Livingston Randall S (Director) Sale 67,500 48.07 3,244,455
2021-02-12 Livingston Randall S (Director) Option Ex 67,500 4.98 336,352
2021-01-25 Hunkapiller Michael (Director) Sale 125,406 36.53 4,580,579
2021-01-25 Hunkapiller Michael (Director) Option Ex 125,406 6.14 769,992
2021-01-22 Hunkapiller Michael (Director) Sale 150,857 36.80 5,550,783
2021-01-22 Hunkapiller Michael (Director) Option Ex 150,857 6.14 926,261
2021-01-21 Hunkapiller Michael (Director) Sale 258,521 37.08 9,586,734
2021-01-21 Hunkapiller Michael (Director) Option Ex 208,711 4.21 877,629
2021-01-20 Hunkapiller Michael (Director) Sale 215,026 40.06 8,613,296
2021-01-20 Hunkapiller Michael (Director) Option Ex 215,026 2.27 488,109
2020-12-22 Hunkapiller Michael (Director) Sale 364,451 25.76 9,388,986
2020-12-22 Hunkapiller Michael (Director) Option Ex 364,451 3.01 1,096,997
2020-12-21 Hunkapiller Michael (Director) Sale 335,549 22.38 7,509,586
2020-12-21 Hunkapiller Michael (Director) Option Ex 335,549 5.29 1,774,047
2020-11-24 Hunkapiller Michael (Director) Sale 1,492 14.38 21,462
2020-11-23 Hunkapiller Michael (Director) Sale 251,837 15.03 3,785,613
2020-11-20 Hunkapiller Michael (Director) Sale 147,799 15.11 2,233,538
2020-11-19 Hunkapiller Michael (Director) Sale 2,201 15.55 34,225
2020-11-18 Hunkapiller Michael (Director) Sale 38,381 15.71 603,003
2020-11-16 Hunkapiller Michael (Director) Sale 42,488 15.89 675,346
2020-11-12 Hunkapiller Michael (Director) Sale 200,000 16.73 3,345,800
2020-11-11 Hunkapiller Michael (Director) Sale 445,652 15.36 6,843,877
2020-11-10 Hunkapiller Michael (Director) Sale 1,304,348 14.25 18,586,959
2020-08-25 Hunkapiller Michael (CEO & President) Sale 228,632 6.44 1,472,618
2020-08-24 Hunkapiller Michael (CEO & President) Sale 259,164 6.63 1,719,553
2020-08-24 Milligan John F (Director) Option Ex 110,000 3.38 372,350
2020-08-21 Hunkapiller Michael (CEO & President) Sale 189,847 6.57 1,246,915
2020-08-20 Hunkapiller Michael (CEO & President) Sale 256,554 6.47 1,659,904
2020-03-24 Phillips James Michael (SVP, Research & Development) Sale 2,760 3.05 8,420
2020-02-20 Phillips James Michael (SVP, Research & Development) Sale 5,050 4.48 22,624
2020-02-20 Hunkapiller Michael (Chairman, CEO & President) Sale 166,575 4.50 749,754
2020-02-19 Hunkapiller Michael (Chairman, CEO & President) Sale 76,281 4.49 342,349
2020-02-19 Barnes Susan K (EVP, CFO and PAO) Sale 12,558 4.44 55,757
2020-02-18 Hunkapiller Michael (Chairman, CEO & President) Sale 525,995 4.49 2,363,295
2019-02-19 Phillips James Michael (SVP, Research & Development) Sale 7,231 7.17 51,817
2019-02-19 Hunkapiller Michael (Chairman, CEO & President) Sale 13,335 7.19 95,825
2019-02-19 Barnes Susan K (EVP, CFO and PAO) Sale 11,987 7.16 85,850
2019-02-19 Ordonez Kathy (Director) Sale 6,933 7.17 49,695
2018-12-20 Barnes Susan K (EVP, CFO and PAO) Option Ex 316,990 3.23 1,023,877
2018-11-27 Ordonez Kathy (Chief Commercial Officer) Sale 25,000 7.54 188,500
2018-11-27 Ordonez Kathy (Chief Commercial Officer) Option Ex 25,000 2.90 72,500
2017-11-24 Corcoran Kevin P (SVP, Market Development) Option Ex 256 1.96 501
2017-07-20 Corcoran Kevin P (SVP, Market Development) Option Ex 28,061 1.96 54,999
2017-06-14 Corcoran Kevin P (SVP, Market Development) Option Ex 84,183 1.96 164,998
2017-06-02 Barnes Susan K (EVP, CFO and PAO) Option Ex 276,238 2.27 627,060
2017-06-01 Hunkapiller Michael (Chairman, CEO & President) Option Ex 500,000 3.01 1,505,000
2016-10-28 Phillips James Michael (SVP, Research & Development) Sale 20,000 8.44 168,720
2016-10-28 Phillips James Michael (SVP, Research & Development) Option Ex 20,000 2.18 43,600
2016-07-29 Phillips James Michael (SVP, Research & Development) Sale 20,000 8.45 168,920
2016-07-29 Phillips James Michael (SVP, Research & Development) Option Ex 20,000 2.07 41,400
2016-04-25 Phillips James Michael (SVP, Research & Development) Sale 20,000 10.29 205,720
2016-04-25 Phillips James Michael (SVP, Research & Development) Option Ex 20,000 1.96 39,200
2016-01-22 Shapiro Lucy (Director) Option Ex 101,666 3.68 373,927
2015-08-07 Phillips James Michael (SVP, Research & Development) Sale 16,689 4.61 77,003
2015-08-07 Phillips James Michael (SVP, Research & Development) Option Ex 31,663 .70 22,164
2015-03-02 Phillips James Michael (SVP, Research & Development) Buy 1,877 4.91 9,221
2015-03-02 Dow Brian B (VP and PAO) Buy 2,503 4.91 12,297
2015-03-02 Corcoran Kevin P (SVP, Market Development) Buy 2,816 4.91 13,835

Insider trading activities including stock purchases, stock sales, and option exercises of PACB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pacific Biosciences Of California, Inc. (symbol PACB, CIK number 1299130) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.